Licoric

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Licoric

Property Description
Active ingredient Allopurinol
Form Oral Tablets, Powder for Intravenous Injection
Pharmacological Class Xanthine Oxidase Inhibitor
General Purpose Urate-Lowering Agent
Origin Synthetic (Purine Analog)

What Type of Medicine is Licoric and What's its Main Component?

The medicine known by the trade name Licoric is a synthetic pharmaceutical product whose active ingredient is Allopurinol, classifying it as a Urate-Lowering Agent. This classification is broadly clinically recognized for chronic management of conditions linked to high uric acid levels. Formally, it belongs to the pharmacological class of Xanthine Oxidase Inhibitors.

This single-active ingredient product is a purine analog designed to address metabolic issues related to uric acid production. Allopurinol is manufactured primarily as Oral Tablets for long-term administration, but it may also be prepared as a sterile Powder for Intravenous Injection for use in clinical settings when the oral route is not feasible. Allopurinol is used for conditions resulting from excessive production of uric acid, which means it helps regulate the body's internal chemistry to prevent buildup of that substance.


How Does Allopurinol Work to Achieve its Purpose?

Licoric's function is centered on controlling the body's overall production of uric acid through a targeted enzyme blockade. The medication achieves this by directly binding to and inhibiting the natural enzyme xanthine oxidase.

By inhibiting this enzyme, Allopurinol disrupts the final steps of purine catabolism, preventing the conversion of precursor substances into uric acid. The fundamental general purpose of this action is the reliable and consistent reduction of serum uric acid concentration. This controlled intervention establishes the necessary chemical conditions for the long-term management of excessive uric acid levels, which is the core benefit of the medication.

Regulatory References

  1. published by the National Library of Medicine (NIH)

What side effects are possible with Licoric?

Possible Side Effects and Safety Information

The safety profile for Licoric, whose active ingredient is Allopurinol, is primarily structured around adverse reactions classified by frequency and the organ system affected, as documented in official regulatory documents (e.g., FDA, EMA).

Common Adverse Reactions

Adverse effects designated as Common include the development of a rash and an increase in Blood thyroid stimulating hormone (TSH) levels. Gastrointestinal issues such as nausea and diarrhea are also frequently reported.

System-Organ Class (SOC) Groupings

Adverse reactions are officially listed across multiple system-organ classes, with notable concerns in:

  • Skin and Subcutaneous Tissue Disorders: Including rash and the rare but serious Severe Cutaneous Adverse Reactions (SCARs).
  • Hepatobiliary Disorders: Documented cases of abnormal liver function tests and hepatitis (liver inflammation).
  • Blood and Lymphatic System Disorders: Potential for severe blood disorders such as agranulocytosis and aplastic anaemia.

Serious Adverse Reactions and Safety Considerations

The regulatory label specifically identifies rare but clinically significant reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Allopurinol Hypersensitivity Syndrome (AHS). These systemic hypersensitivity reactions represent the highest safety concern documented.

For patients with renal impairment, special consideration is given due to the medicine’s primary route of elimination through the kidneys. Furthermore, an increase in acute gout attacks is officially noted to occur during the early stages of administration.

Overdose and Emergency Response

Overdose and when to seek help

Documented Manifestations and Emergency Action

The official regulatory documentation indicates that there is no clinical experience in managing patients who have taken massive, single-dose quantities of Allopurinol tablets. Due to this absence of clinical data for acute, massive ingestion, immediate medical attention must be sought if an overdose is suspected, regardless of the presence of immediate symptoms. Urgent medical care providers must be contacted immediately, as any massive exposure is considered a severe scenario requiring hospital monitoring.

Supportive Management and Antidote Status

The official strategy for addressing overdose focuses on procedural and supportive management. It is explicitly stated in regulatory labeling that no specific antidote is known for Allopurinol overdose. Treatment is therefore strictly symptomatic and supportive.

Both the active drug and its metabolite, oxipurinol, are classified as dialyzable substances in the official prescribing information. However, the regulatory documents also note that the usefulness of specific interventions, such as hemodialysis or peritoneal dialysis, in the actual management of overdose is currently unknown due to limited data. Therefore, seeking professional medical assessment without delay is the primary required action.

Therapeutic Uses of Licoric

What Licorice Treats: Main Uses and Benefits

Licorice root is commonly used across conditions presenting with systemic or localized discomfort and symptoms related to physical discomfort. It has a long history of use in traditional practices. A common summary is: “It is applied across domains where additional symptomatic support is needed.”

Licorice may be part of symptomatic management relevant for easing symptoms related to inflammatory or irritative states. It may assist with managing symptoms that interfere with daily comfort across several areas, including digestive support, respiratory support, and discomfort associated with canker sores, sore throats, and certain skin conditions. Applied in scenarios where additional management of discomfort is required, licorice contributes to improved comfort during periods of heightened symptoms. It supports general well-being during symptomatic phases by helping ease the overall symptom burden.

Quick Fact: Relief for Sore Throats

Regulatory References

  1. NIH MedlinePlus overview of Licorice Root

Eligibility and Restrictions for Use

Who Can and Cannot Use Licoric?

Eligibility for using medicinal products containing licorice (or its active component, glycyrrhizin) is strictly defined by regulatory bodies to exclude populations at risk due to its effects on fluid and electrolyte balance, and hormonal systems. This information is based solely on authoritative governmental documentation.


Formal Eligibility Restrictions

Certain physiological states and pre-existing conditions render the use of licorice contraindicated or not recommended.

Classification Population/Condition
Contraindicated Pregnancy
Contraindicated Pre-existing Hypokalemia (low blood potassium)
Not Recommended Breastfeeding
Not Recommended History of Hypertension (high blood pressure)
Not Recommended Heart Failure or severe Kidney Disease
Special Consideration Hormone-sensitive conditions (e.g., certain cancers)
Special Consideration Pediatric or Geriatric Populations (use often not established or restricted)

Official Eligibility Summary

Use is formally prohibited for pregnant individuals and those diagnosed with low blood potassium, as these situations pose a high risk of adverse outcomes as documented in official labeling. Use is also strongly advised against for individuals with underlying cardiovascular, renal, or estrogen-sensitive conditions, as the drug may exacerbate these issues. Use in children is generally not established, limiting eligibility to specific adult populations without contraindications.

What should I know about interactions with other medicines?

The official regulatory profile for Licoric (Allopurinol) establishes several specific constraints regarding co-administration with other medicines, categorized by pharmacokinetic and pharmacodynamic effects.

Prohibited Combinations and Severe Constraints

Co-administration with Pegloticase and Didanosine is contraindicated due to official restrictions on treatment monitoring or a significant increase in toxicity risk, respectively. The combination with Azathioprine or Mercaptopurine is highly restricted; if necessary, the dose of the antimetabolite must be reduced to approximately one-quarter of the usual dose because Allopurinol inhibits its metabolism, leading to a risk of severe myelosuppression.


Exposure-Modifying Interactions

Allopurinol may affect the plasma concentrations of several medicines. It may inhibit the metabolism of Warfarin, potentially enhancing its anticoagulant effect, and increases the plasma levels of Cyclosporine. Co-administration with Theophylline at higher Allopurinol doses (600 mg/day) can decrease Theophylline clearance. Conversely, Uricosuric Agents like Probenecid accelerate the excretion of Allopurinol’s active metabolite, which may reduce its overall activity.


Increased Adverse Event Risk

Thiazide Diuretics and ACE Inhibitors are associated with a synergistic adverse event risk where co-administration increases the likelihood of severe hypersensitivity and skin reactions, particularly in patients with pre-existing decreased renal function. A separate timing rule is mandated for certain antacids: Aluminum Hydroxide must be administered with a three-hour gap from the Allopurinol dose.

Mechanism of Action

️ How Licoric Works


Inhibition of Xanthine Oxidase

The mechanism involves the inhibition of the enzyme Xanthine Oxidase (XO) by its active species, Oxypurinol. This molecular interaction directly blocks the final chemical steps of purine catabolism, preventing the conversion of precursor molecules into uric acid. This production-limiting mechanism acts systemically.


Interruption of the Uric Acid Synthesis Cascade

By inhibiting XO, the drug interrupts the natural purine synthesis cascade. This causes the highly soluble purine precursors, Hypoxanthine and Xanthine, to accumulate, triggering a feedback loop that slows the body's de novo creation of new purines. This dual action results in the continuous lowering of the overall rate of uric acid production in the body.


Maintenance of the Hypouricemic State

The drug establishes a sustained hypouricemic state, meaning a continuous, low concentration of uric acid is maintained in plasma and tissues. This physiological consequence is enabled by the long half-life of Oxypurinol, ensuring the enzyme blockade is persistent. This state maintains a reduction in the total systemic uric acid load.

Dosage and Administration Information

How to Use Licoric: Official Administration Guidelines

The use of Licoric (Allopurinol) is defined by official product labeling, which outlines precise instructions for administration routes, dosing, and intake conditions. The medicine is primarily available for long-term use as Oral Tablets, but a Sterile Powder for Intravenous (IV) infusion is available for patients when the oral route is not clinically feasible, such as during specialized cancer therapy.


Dosage and Titration Protocol

Official instructions mandate a titration-based dosing approach for the oral form. Treatment typically begins with a low dose, such as 100 mg once daily. The dose is then gradually increased, often in weekly increments, to achieve a specific target serum level. The maximum recommended daily dosage for adults is 800 mg. If the total daily dose exceeds 300 mg, it may be administered in divided amounts to reduce potential gastrointestinal irritation.


Contextual Administration Rules and Adjustments

Oral tablets should be taken after meals. A crucial requirement is to ensure the consumption of plenty of liquids alongside the medicine to promote high urinary output, which is a key procedural condition for proper use. Furthermore, for patients with impaired kidney function, regulatory guidelines explicitly require a reduction in the starting and maintenance dose. In cases of severe renal impairment, the initial dose may be as low as 50 mg daily, reflecting a necessary adjustment to the standard regimen.

Recent Clinical Evidence

Licoric: Recent Clinical Evidence

Research on the compound Licoric (derived from Glycyrrhiza glabra root, with glycyrrhizin as a key component) primarily explores its potential use in supportive care and specific health areas, though high-quality evidence remains limited for most conditions.

Key Areas of Study

Clinical trials have investigated Licoric's effect across several systems. Findings indicate a potential role in:

  • Oral Health: Preliminary evidence suggests that a Licoric mouth rinse or gargle may be associated with a reduction in the size and pain of recurrent canker sores. Gargling with a Licoric solution prior to surgery was evaluated for its potential to reduce the incidence and severity of postoperative sore throat.
  • Liver and Metabolic Health: Studies have evaluated Licoric supplementation, often as an adjunct to lifestyle modification, for its association with changes in liver enzymes and markers of insulin resistance in women with non-alcoholic fatty liver disease (NAFLD).
  • Skin Conditions: Topical Licoric preparations have been studied for their effect on symptoms of atopic dermatitis (eczema) and burn healing, showing some initial promising outcomes in small-scale trials.
Condition Studied Primary Research Focus
Oral Ulcers (Canker Sores) Symptom reduction (pain and size)
Postoperative Sore Throat Prevention/Reduction of severity
Nonalcoholic Fatty Liver Disease Changes in liver enzyme levels

Safety Considerations in Research

In studies focusing on safety, the main component glycyrrhizin has been consistently linked to dose-dependent effects on blood pressure and electrolyte balance. Consumption of Licoric can lead to pseudohyperaldosteronism, characterized by increased blood pressure and low potassium levels (hypokalemia). Due to this potential, caution is necessary, especially for individuals with pre-existing hypertension or heart/kidney conditions. Research evaluating Licoric's interaction with FDA-approved medications, particularly those affecting the cardiovascular system, is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Licoric (FAQ)


Q: What should I do if I miss a dose of Licoric?

If a dose is missed, official patient instructions state that it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Product information states that two doses should not be taken at the same time to make up for a missed dose.


Q: What are the symptoms of an allergic reaction to Licoric that require immediate medical attention?

The official product information warns about rare but serious reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). These may begin with general flu-like symptoms like a fever and sore throat, followed by a painful, spreading rash, blistering, and peeling of the skin on the body and in the mouth. If you notice any of these serious symptoms, immediate emergency medical attention is required.


Q: Can Licoric be crushed or chewed if I have trouble swallowing pills?

Licoric tablets are generally designed to be swallowed whole. While official patient information leaflets do not explicitly instruct patients to crush or chew them, specialized guidelines sometimes suggest the tablet can be crushed for alternate administration methods like feeding tubes. Any modification to the tablet form should only be done after consulting with a healthcare professional.


Q: How long does it take for Licoric to start working and lower uric acid levels?

Studies and official information indicate that the process of lowering uric acid levels begins relatively quickly, often within 24 to 48 hours of starting treatment. However, the maximum therapeutic effect and the sustained, low uric acid state are typically achieved after continuous use for one to three weeks.


Q: I have kidney failure. What is the recommended starting dose of Licoric for me?

Official regulatory documents specify dose reductions for patients with impaired kidney function, which is assessed based on creatinine clearance. For example, for patients with very low clearance, a 100 mg/day starting dose is often indicated. The exact dose, which may be lower than the standard dose, is determined by a healthcare provider based on your specific level of kidney function.


Q: Can I take Licoric with Warfarin? Will it change how Warfarin works?

Regulatory documents indicate that co-administering Licoric with Warfarin may increase the blood-thinning effect of Warfarin. If the two medications are taken together, careful monitoring of anticoagulation status, such as the International Normalized Ratio (INR), is typically necessary, and dose adjustment for Warfarin may be indicated.


Q: Does Licoric commonly cause hair loss or changes to vision?

The official safety profile for Licoric lists adverse events like hair loss (alopecia), cataracts, and other visual changes. However, these are classified as rare reactions, meaning they are reported by less than 1 in 1,000 users. They are not considered common side effects of the medication.

How should Licoric be stored and disposed of?

How to Store and Dispose of Allopurinol (Licoric)

Storage and disposal must strictly follow official regulatory documentation to maintain product stability and safety.

Storage Requirements

Product Form Required Conditions
Oral Tablets Store at controlled room temperature (20 C to 25 C). Keep in the original container, tightly closed.
IV Powder Store below 25 C and protect from light. Reconstituted solution has stability limits (e.g., 10 hours at room temperature).

All forms must be kept out of the sight and reach of children.

Disposal

Unused or expired Allopurinol must be disposed of in accordance with local requirements. Official guidelines state the product should not be disposed of via wastewater or household waste to protect the environment. Drug take-back programs are the preferred disposal method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Licoric found in:

A-Z Index: